Cite
APA Citation
Hsu, C., Rimassa, L., Sun, H., Vogel, A., & Kaseb, A. O. (2021). immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab. Therapeutic advances in medical oncology, 13, . http://access.bl.uk/ark:/81055/vdc_100125807783.0x0000f9